Dulbecco's Modified Eagle Medium (DMEM) Medium Equipment Market Report 2026

The dulbecco’s modified eagle medium (dmem) medium equipment market size has grown strongly in recent years. It will grow from $1.36 billion in 2025 to $1.48 billion in 2026 at a compound annual growth rate (CAGR) of 8.5%. The growth in the historic period can be attributed to expansion of mammalian cell culture research, growth of biopharmaceutical manufacturing, increasing academic life science research, rising use of standardized culture media, availability of advanced laboratory infrastructure.

The dulbecco’s modified eagle medium (dmem) medium equipment market size is expected to see strong growth in the next few years. It will grow to $2.02 billion in 2030 at a compound annual growth rate (CAGR) of 8.2%. The growth in the forecast period can be attributed to increasing investments in cell-based therapies, rising demand for automated laboratory workflows, expansion of regenerative medicine research, growing focus on reproducibility in experiments, increasing adoption of smart lab technologies. Major trends in the forecast period include increasing adoption of automated dmem preparation systems, rising demand for high-precision cell culture equipment, growing integration of hybrid medium preparation technologies, expansion of scalable bioreactor-based systems, enhanced focus on sterility and process consistency.

The increasing demand for biological drugs is expected to drive the growth of the Dulbecco’s Modified Eagle Medium (DMEM) medium equipment market in the coming years. Biological drugs are medications derived from living organisms or their components, such as proteins or antibodies, used to treat conditions like cancer, autoimmune diseases, and genetic disorders. Demand for biologics is rising as healthcare systems and manufacturers expand production to address chronic, oncologic, and rare-disease treatments. Dulbecco’s Modified Eagle Medium (DMEM) medium equipment supports biological drugs by facilitating reproducible medium preparation, precise physicochemical control, and scalable handling that manufacturers and laboratories require for consistent cell-based biologic production. For example, in February 2025, the World Health Organization reported that, as of 2023, a Switzerland-based health authority included 81 biologic therapies in the WHO Essential Medicines List, representing over 15% of all listed essential medicines. Therefore, the growing demand for biological drugs is fueling the expansion of the Dulbecco’s Modified Eagle Medium (DMEM) medium equipment market.

The increasing investments in biopharmaceuticals are expected to drive the growth of the Dulbecco’s Modified Eagle Medium (DMEM) equipment market in the coming years. Investment in biopharmaceuticals refers to the allocation of financial resources toward the research, development, and commercialization of pharmaceutical products. Investments in the biopharmaceutical sector are growing due to the rising global demand for innovative therapies targeting complex and chronic diseases, such as cancer, autoimmune disorders, and rare genetic conditions. Investments in biopharmaceuticals support Dulbecco’s Modified Eagle Medium (DMEM) equipment by promoting the adoption of advanced cell culture systems, enabling the procurement of automated equipment, and facilitating the scaling of research and production processes. For example, in January 2025, according to the BioIndustry Association (BIA), a UK-based non-profit organization, the UK biotech sector secured $4.3 billion USD (£3.5 billion) in investment in 2024, marking a significant 94% increase from the previous year. Therefore, the rising investments in biopharmaceuticals are fueling the growth of the Dulbecco’s Modified Eagle Medium (DMEM) equipment market.

Major companies operating in the Dulbecco’s Modified Eagle Medium (DMEM) equipment market are emphasizing automation and miniaturization, including automated cell culture systems, to improve operational efficiency, minimize manual intervention, and enhance reproducibility of experimental outcomes. Automated cell culture systems are laboratory platforms that utilize robotics and sensors to carry out cell culture procedures with minimal human involvement, providing precise control, consistency, and scalability for research and biopharmaceutical applications. For example, in May 2025, Multus Biotechnology Ltd., a UK-based biotechnology firm, introduced a new food-grade basal media called DMEM/F12-FG, specifically developed for cultivated meat production. This product is formulated to support cell growth by supplying essential nutrients such as sugars, salts, minerals, and vitamins, all meeting food-grade standards. Developed in collaboration with global food and feed ingredient companies and leveraging AI for optimal formulation, it is designed to enable scalable and regulatory-compliant cultivated meat manufacturing. The media is offered in 500 ml and 1-liter bottles from certified manufacturing facilities, allowing companies and researchers to test and accelerate their development processes aimed at commercial production.

Major companies operating in the dulbecco’s modified eagle medium (dmem) medium equipment market are Thermo Fisher Scientific Inc., Merck KGaA, FUJIFILM Irvine Scientific Inc., GE Healthcare Technologies Inc., Corning Incorporated, Lonza Group Ltd., Avantor Inc., Agilent Technologies Inc., Sartorius AG, Bio-Techne Corporation, MP Biomedicals LLC, HiMedia Laboratories Pvt. Ltd., Creative Bioarray Inc., Capricorn Scientific GmbH, US Biological Life Sciences Inc., PhytoTech Labs Inc., Alkali Scientific LLC, Genexis Biotech Pvt. Ltd., STEMCELL Technologies Inc., Bioartha Labs Private Limited.

North America was the largest region in the dulbecco’s modified eagle medium (DMEM) medium equipment market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the dulbecco’s modified eagle medium (dmem) medium equipment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the dulbecco’s modified eagle medium (dmem) medium equipment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs are impacting the DMEM medium equipment market by increasing costs of imported bioreactors, filtration units, centrifuges, sensors, and automation components used in medium preparation and cell culture workflows. Research institutions and biomanufacturing facilities in North America and Europe are most affected due to reliance on imported laboratory equipment, while Asia-Pacific faces higher costs for export-oriented equipment manufacturing. These tariffs are raising capital expenditure and delaying lab upgrades. However, they are also encouraging local equipment production, regional supplier development, and modular system innovation.

The dulbecco’s modified eagle medium (dmem) medium equipment market research report is one of a series of new reports that provides dulbecco’s modified eagle medium (dmem) medium equipment market statistics, including dulbecco’s modified eagle medium (dmem) medium equipment industry global market size, regional shares, competitors with a dulbecco’s modified eagle medium (dmem) medium equipment market share, detailed dulbecco’s modified eagle medium (dmem) medium equipment market segments, market trends and opportunities, and any further data you may need to thrive in the dulbecco’s modified eagle medium (dmem) medium equipment industry. This dulbecco’s modified eagle medium (dmem) medium equipment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Dulbecco’s modified Eagle medium (DMEM) equipment refers to specialized laboratory systems utilized for the preparation and maintenance of Dulbecco’s modified Eagle medium (DMEM), a nutrient-rich formulation crucial for supporting mammalian cell cultures. This equipment ensures that the medium maintains its necessary physicochemical balance, promoting consistent cell growth, metabolism, and experimental reliability in research and biomanufacturing applications.

The main types of Dulbecco’s Modified Eagle Medium (DMEM) equipment include cell culture equipment, bioreactors, filtration systems, centrifuges, and incubators. Cell culture equipment refers to the specialized tools and devices used to grow and maintain cells under controlled laboratory conditions. It incorporates various technologies, such as automated DMEM preparation, manual DMEM preparation, and hybrid DMEM preparation, and is distributed through direct sales, online sales, distributors, and resellers. It is applied in cell culture, tissue engineering, drug development, and other areas, serving end-users such as biotechnology companies, pharmaceutical companies, research institutions, academic institutions, and contract research organizations (CROs).

The dulbecco’s modified eagle medium (DMEM) medium equipment market consists of sales of water bath systems, micropipette controllers, CO₂ monitors, shakers and mixers, and sterile workstations. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.